Skip to main content
OpenTrials

Clinical trial condition

Esophageal Adenocarcinoma

Explore clinical trials studying Esophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

93 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Adenocarcinoma trial results

Active, Not Recruiting

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

NCT06628310

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, +1 more
Locations
  • City of Hope National Medical Center /ID# 268690 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 272630 Irvine, California, United States
  • UCLA - Santa Monica /ID# 270024 Santa Monica, California, United States
  • AdventHealth Orlando /ID# 268561 Orlando, Florida, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

NCT05152147

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Hospital de Gastroenterología Dr Bonorino Udaondo Buenos Aires, Argentina
  • Instituto de Investigaciones Metabólicas - IDIM Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Fundación Centro de Medicina Nuclear y Molecular ER Córdoba, Argentina
View all 227 locations
View Trial Details
Active, Not Recruiting

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

NCT02521285

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

NCT05480384

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Weill Cornell Medicine/New York-Presbyterian New York, United States
  • Lifespan Cancer Institute Providence, Rhode Island, United States
View Trial Details
Active, Not Recruiting

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

NCT05945823

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +22 more
Locations
  • University of California Los Angeles UCLA - Cancer Care - Santa Monica Santa Monica, California, United States
  • Rocky Mountain Cancer Centers Midtown Denver, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

NCT02998268

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma
Locations
  • USC Keck School of Medicine, Norris Cancer Center Los Angeles, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Weill Cornell Medicine New York, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details

Related conditions